新型冠狀病毒

Countries across Europe suspend use of Oxford-AstraZeneca jab

WHO urges authorities not to pause vaccinations despite blood clot fears as UK stands by approval

Countries across Europe have suspended the Oxford/AstraZeneca Covid-19 vaccine over concerns the jab may cause blood clots, even though medicines regulators and the World Health Organization say there is no evidence of problems.

Germany, Italy, France, Spain and the Netherlands became the latest countries to pause the rollout of the jab on Monday. Norway, Denmark and Bulgaria suspended their programmes last week.

The suspensions came as the WHO urged nations not to pause Oxford/AstraZeneca inoculation programmes, having said last week there was no sign the problems had been caused by the jab. Boris Johnson, the UK prime minister, said Britain’s medicines regulator saw “no reason to discontinue” use of the vaccine, with Downing Street asserting that the jab was both “safe and effective”.

您已閱讀16%(795字),剩餘84%(4302字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×